272 related articles for article (PubMed ID: 19665938)
21. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
22. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
Brannan SK; Mallinckrodt CH; Detke MJ; Watkin JG; Tollefson GD
J Psychiatr Res; 2005 Mar; 39(2):161-72. PubMed ID: 15589564
[TBL] [Abstract][Full Text] [Related]
23. Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
Gaynor P; McCarberg B; Zheng W; Shoemaker S; Duenas H
Int J Clin Pract; 2011 Mar; 65(3):341-9. PubMed ID: 21314871
[TBL] [Abstract][Full Text] [Related]
24. The Clinical Relevance of Pain Severity Changes: Is There Any Difference Between Asian and Caucasian Patients With Osteoarthritis Pain?
Yue L; Wang J; Enomoto H; Fujikoshi S; Alev L; Cheng YY; Skljarevski V
Pain Pract; 2020 Feb; 20(2):129-137. PubMed ID: 31505082
[TBL] [Abstract][Full Text] [Related]
25. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
Arnold LM; Palmer RH; Gendreau RM; Chen W
Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218
[TBL] [Abstract][Full Text] [Related]
26. Duloxetine: in patients with fibromyalgia.
Curran MP
Drugs; 2009 Jun; 69(9):1217-27. PubMed ID: 19537838
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
28. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
[TBL] [Abstract][Full Text] [Related]
29. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
Pollack MH; Endicott J; Liebowitz M; Russell J; Detke M; Spann M; Ball S; Swindle R
J Psychiatr Res; 2008 Oct; 42(12):1042-9. PubMed ID: 18221755
[TBL] [Abstract][Full Text] [Related]
30. Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.
Demyttenaere K; Desaiah D; Petit C; Croenlein J; Brecht S
Curr Med Res Opin; 2012 Jan; 28(1):41-8. PubMed ID: 22126422
[TBL] [Abstract][Full Text] [Related]
31. Patient-perceived satisfactory improvement (PPSI): interpreting meaningful change in pain from the patient's perspective.
ten Klooster PM; Drossaers-Bakker KW; Taal E; van de Laar MA
Pain; 2006 Mar; 121(1-2):151-7. PubMed ID: 16472915
[TBL] [Abstract][Full Text] [Related]
32. History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.
Pae CU; Masand PS; Marks DM; Krulewicz S; Han C; Peindl K; Mannelli P; Patkar AA
World J Biol Psychiatry; 2009; 10(4 Pt 2):435-41. PubMed ID: 19382010
[TBL] [Abstract][Full Text] [Related]
33. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial.
Farrar JT; Troxel AB; Stott C; Duncombe P; Jensen MP
Clin Ther; 2008 May; 30(5):974-85. PubMed ID: 18555944
[TBL] [Abstract][Full Text] [Related]
34. Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
Hall JA; Wang F; Oakes TM; Utterback BG; Crucitti A; Acharya N
Expert Opin Drug Saf; 2010 Jul; 9(4):525-37. PubMed ID: 20465525
[TBL] [Abstract][Full Text] [Related]
35. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
Chappell AS; Littlejohn G; Kajdasz DK; Scheinberg M; D'Souza DN; Moldofsky H
Clin J Pain; 2009 Jun; 25(5):365-75. PubMed ID: 19454869
[TBL] [Abstract][Full Text] [Related]
36. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
Fishbain DA; Hall J; Meyers AL; Gonzales J; Mallinckrodt C
J Pain Symptom Manage; 2008 Dec; 36(6):639-47. PubMed ID: 18504092
[TBL] [Abstract][Full Text] [Related]
37. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
Allgulander C; Hartford J; Russell J; Ball S; Erickson J; Raskin J; Rynn M
Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
[TBL] [Abstract][Full Text] [Related]
39. Estimation of clinically important change for visual analog scales measuring chronic temporomandibular disorder pain.
Emshoff R; Emshoff I; Bertram S
J Orofac Pain; 2010; 24(3):262-9. PubMed ID: 20664827
[TBL] [Abstract][Full Text] [Related]
40. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]